Finance

.1 At median follow-up of almost three years (34 months), median OS was not reached for patients in the CARVYKTI ® ...

Josh Funk, The Associated Press

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/news/news_six_pile_69x52._800x533_L_1419494215.jpg https://www.investing.com/news/insider-trading-news/broadcom-director-sells-shares-worth-over-130000-93CH-3637246 Investing.com

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/ge-healthcares-flyrcado-gets-fda-approval-for-cad-detection-93CH-3637247 Investing.com

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/poseida-reports-high-response-in-multiple-myeloma-trial-93CH-3637248 Investing.com

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/know-labs-ratifies-auditor-and-board-elections-93CH-3637205 Investing.com

; I do have sort of a hard time justifying getting really excited over the next few months," Calvasina told CNBC's " Squawk...

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/news/World_News_10_800x533_L_1420026292.jpg https://www.investing.com/news/insider-trading-news/renaissancere-executive-sells-shares-worth-269000-93CH-3637145 Investing.com

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/salarius-pharmaceuticals-sets-date-for-2024-annual-meeting-93CH-3637146 Investing.com